Showing results (71-80 of 94) with videos related to
Sort By:
Pageof 10
Leukemia Research|November 11, 2019
Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in JapanTakako Miyamura, Kazuko Kudo, Ken Tabuchi, et al.Bone Marrow Transplantation|May 24, 2020
Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamideNao Yoshida, Yoshiyuki Takahashi, Hiromasa Yabe, et al.International Journal of Clinical Oncology|June 6, 2018
Secondary cancer after a childhood cancer diagnosis: viewpoints considering primary cancerYasushi Ishida, Miho Maeda, Souichi Adachi, et al.International Journal of Hematology|September 27, 2013
Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study GroupDaisuke Tomizawa, Akio Tawa, Tomoyuki Watanabe, et al.International Journal of Clinical Oncology|December 2, 2015
Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in JapanYasushi Ishida, Dongmei Qiu, Miho Maeda, et al.Haematologica|May 13, 2014
Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemiaHirotoshi Sakaguchi, Nobuhiro Nishio, Asahito Hama, et al.International Journal of Hematology|June 26, 2014
Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocolHideki Nakayama, Ken Tabuchi, Akio Tawa, et al.Blood|June 21, 2003
Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndromeGang Xu, Masumi Nagano, Rika Kanezaki, et al.Pediatric Blood & Cancer|December 5, 2013
Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndromeHideki Muramatsu, Hirotoshi Sakaguchi, Takashi Taga, et al.Pediatric Blood & Cancer|October 21, 2015
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in JapanTakashi Taga, Tomoyuki Watanabe, Daisuke Tomizawa, et al.Pageof 10